About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

1.202 -0.028 (-2.29%)

Streaming Delayed Price Updated: 1:16 PM EST, Dec 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 Next >

Which stocks are gapping on Monday? ↗

December 01, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Biotech Giant MAIA Biotechnology (NYSE American: MAIA) Dives Headfirst into Crypto with Audacious Treasury Strategy

October 07, 2025

October 7, 2025 – In a move that sent ripples across both the biotechnology and cryptocurrency sectors, MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company...

Via BreakingCrypto

Topics ETFs Economy

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 02, 2025

Via Benzinga

MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars ↗

June 18, 2025

The agreement aims to support future studies investigating the combination of MAIA’s Ateganosine and Roche’s checkpoint inhibitor, Atezolizumab, for safe and effective cancer treatments.

Via Stocktwits

MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients ↗

June 05, 2025

MAIA posts 17.8-month median survival in NSCLC trial, nearly tripling standard care; long-term response seen in a chemo- and immunotherapy-resistant group.

Via Benzinga

MAIA Biotechnology's Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits

September 11, 2024

MAIA Biotechnology's Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits

Via News Direct

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024 ↗

August 16, 2024

MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients ↗

July 23, 2024

MAIA Biotechnology's Phase 2 THIO-101 trial shows promising updates for THIO with Regeneron's cemiplimab in advanced NSCLC patients. Results include a 38% ORR, 85% DCR, and lower toxicity, with six...

Via Benzinga

Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 23, 2024

Via Benzinga

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 07, 2024

Via Benzinga

New Clinical Data Reveals MAIA Biotechnology's THIO Achieves High Efficacy In Advanced Non-Small Cell Lung Cancer Treatment

June 07, 2024

--News Direct--

Via News Direct

Topics Death

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 05, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 04, 2024

Via Benzinga

MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market

May 22, 2024

MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market

Via News Direct

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024 ↗

May 15, 2024

MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q4 2023 ↗

March 21, 2024

MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

MAIA Biotech Completes Enrollment For Phase 2 Trial Of Its Candidate THIO To Fight Non-Small Cell Lung Cancer

February 29, 2024

--News Direct--

Via News Direct

MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential ↗

February 22, 2024

MAIA Biotechnology, a biotechnology company developing innovative cancer treatments, has seen its stock drift downwards for the past months.

Via Talk Markets

Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA ↗

February 06, 2024

Vlad Vitoc, MD, MBA; CEO & Chairman of MAIA Biotechnology (NYSE: MAIA), was a guest on Benzinga’s All Access. MAIA is a targeted therapy immuno-oncology company focused on developing and...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 17, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 15, 2024

Via Benzinga

Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 12, 2024

Shares of Wipro Limited (NYSE: WIT) rose sharply during Friday’s session after the company reported third-quarter financial results, issued guidance and declared an interim dividend. Wipro shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

January 12, 2024

Via Benzinga

Why VCI Global Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket ↗

January 12, 2024

Shares of VCI Global Limited (NASDAQ: VCIG) fell sharply in pre-market trading after the company announced pricing of $2.75 million public offering. VCI Global shares tumbled 29.5% to $1.10 in...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 12, 2024

We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 09, 2024

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

Headline News about MAIA Biotechnology, Inc. Common Stock

Sections

Services

Contact Information

Follow Us